Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Nuklearmedizin. Nuclear Medicine|July 22, 2020
Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningiomaMichael Müther, Wolfgang Roll, Benjamin Brokinkel, et al.Cancers|February 15, 2022
Combined Fluorescence-Guided Resection and Intracavitary Thermotherapy with Superparamagnetic Iron-Oxide Nanoparticles for Recurrent High-Grade Glioma: Case Series with Emphasis on Complication ManagementMichael Schwake, Michael Müther, Ann-Katrin Bruns, et al.Journal of Neurosurgery|January 6, 2019
Second-look strokectomy of cerebral infarction areas in patients with severe herniationMichael Schwake, Stephanie Schipmann, Michael Müther, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 22, 2025
Multidisciplinary treatment is necessary in glioblastoma with extracerebral metastasesNiklas B Pepper, David R Steike, Heidi Yppärilä-Wolters, et al.Cancers|November 9, 2024
Efficacy and Low Toxicity of Normo-Fractionated Re-Irradiation with Combined Chemotherapy for Recurrent Glioblastoma-An Analysis of Treatment Response and FailureNiklas Benedikt Pepper, Nicholas Grischa Prange, Fabian Martin Troschel, et al.EJNMMI Research|September 4, 2023
First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot studyWolfgang Roll, Michael Müther, Guido Böning, et al.World Neurosurgery|August 4, 2020
Somatostatin Receptor-Targeted Radioligand Therapy in Head and Neck ParagangliomaWolfgang Roll, Michael Müther, Peter B Sporns, et al.Brain & Spine|April 11, 2024
Revitalizing neurosurgical frontiers: The EANS frontiers in neurosurgery committee's strategic frameworkAaron Lawson McLean, Ignazio G Vetrano, Anna C Lawson McLean, et al.Theranostics|January 27, 2021
Imaging temozolomide-induced changes in the myeloid glioma microenvironmentClaudia Foray, Silvia Valtorta, Cristina Barca, et al.Neuro-Oncology|February 13, 2020
TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant gliomaBastian Zinnhardt, Michael Müther, Wolfgang Roll, et al.Pageof 6